$321 Million is the total value of Krensavage Asset Management, LLC's 16 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $50,862,000 | +7.2% | 866,770 | -14.5% | 15.85% | +7.2% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $43,561,000 | +7.3% | 294,429 | -15.0% | 13.58% | +7.3% |
| Buy | BIOVERATIV INC | $39,376,000 | +9.6% | 730,260 | +16.0% | 12.27% | +9.6% | |
| GILD | Sell | GILEAD SCIENCES INC | $34,248,000 | -18.9% | 478,053 | -8.2% | 10.68% | -18.9% |
| SCMP | Sell | SUCAMPO PHARMACEUTICALS-CL A | $23,414,000 | -30.0% | 1,304,376 | -54.0% | 7.30% | -30.0% |
| MCK | New | MCKESSON CORP | $19,725,000 | – | 126,482 | +100.0% | 6.15% | – |
| IVC | Sell | INVACARE CORP | $18,666,000 | +5.4% | 1,107,770 | -1.5% | 5.82% | +5.4% |
| HYH | Sell | HALYARD HEALTH INC | $18,242,000 | -15.4% | 395,015 | -17.5% | 5.69% | -15.4% |
| RTIX | Sell | RTI SURGICAL INC | $17,773,000 | -11.5% | 4,334,852 | -1.8% | 5.54% | -11.5% |
| OFIX | Sell | ORTHOFIX INTERNATIONAL NV | $17,742,000 | -22.9% | 324,357 | -33.4% | 5.53% | -22.9% |
| AMGN | New | AMGEN INC | $15,212,000 | – | 87,477 | +100.0% | 4.74% | – |
| MRK | Sell | MERCK & CO. INC. | $8,973,000 | -63.5% | 159,466 | -58.4% | 2.80% | -63.5% |
| CNMD | Sell | CONMED CORP | $8,387,000 | -16.6% | 164,547 | -14.1% | 2.61% | -16.6% |
| JNP | Buy | JUNIPER PHARMACEUTICALS INC | $2,134,000 | +92.9% | 440,102 | +81.0% | 0.66% | +92.8% |
| AVIR | Sell | AVIRAGEN THERAPEUTICS INC | $1,591,000 | -18.1% | 2,809,531 | -0.9% | 0.50% | -18.2% |
| DRAD | Buy | DIGIRAD CORP | $912,000 | -20.9% | 354,179 | +6.0% | 0.28% | -20.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.